Literature DB >> 7499301

Prevention of in vitro protein thermal aggregation by the Sulfolobus solfataricus chaperonin. Evidence for nonequivalent binding surfaces on the chaperonin molecule.

A Guagliardi1, L Cerchia, M Rossi.   

Abstract

We have studied the effects of the Sulfolobus solfataricus chaperonin on the aggregation and inactivation upon heating of four model enzymes: chicken egg white lysozyme (one 14.4-kDa chain), yeast alpha-glucosidase (one 68.5-kDa chain), chicken liver malic enzyme (four 65-kDa subunits), and yeast alcohol dehydrogenase (four 37.5-kDa subunits). When the proteins were heated in the presence of an equimolar amount of chaperonin, 1) the aggregation was prevented in all solutions; 2) the inactivation profiles of the single-chain enzymes were comparable with those detected in the absence of the chaperonin, and enzyme activities were regained in the solutions heated in the presence of the chaperonin upon ATP hydrolysis (78 and 55% activity regains for lysozyme and alpha-glucosidase, respectively); 3) the inactivation of the tetrameric enzymes was completely prevented, whereas the activities decreased in the absence of the chaperonin. We demonstrate by gel filtration chromatography that the chaperonin interacted with the structures occurring during thermal denaturation of the model proteins and that the interaction with the single-chain proteins (but not that with the tetrameric proteins) was reversed upon ATP hydrolysis. The chaperonin had nonequivalent surfaces for the binding of the model proteins upon heating: the thermal denaturation intermediates of the single-chain proteins share Surfaces I, while the thermal denaturation intermediates of the tetrameric proteins share Surfaces II. ATP binding to the chaperonin induced a conformation that lacked Surfaces I and carried Surfaces II. These data support the concept that chaperonins protect native proteins against thermal aggregation by two mechanistically distinct strategies (an ATP-dependent strategy and an ATP-independent strategy), and provide the first evidence that a chaperonin molecule bears functionally specialized surfaces for the binding of the protein substrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499301     DOI: 10.1074/jbc.270.47.28126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Nucleolar protein B23 has molecular chaperone activities.

Authors:  A Szebeni; M O Olson
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  The Sso7d protein of Sulfolobus solfataricus: in vitro relationship among different activities.

Authors:  Annamaria Guagliardi; Laura Cerchia; Mosè Rossi
Journal:  Archaea       Date:  2002-09       Impact factor: 3.273

3.  The chaperonin of the archaeon Sulfolobus solfataricus is an RNA-binding protein that participates in ribosomal RNA processing.

Authors:  D Ruggero; A Ciammaruconi; P Londei
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

4.  Acquired thermotolerance and temperature-induced protein accumulation in the extremely thermophilic bacterium Rhodothermus obamensis.

Authors:  K Takai; T Nunoura; Y Sako; A Uchida
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

5.  Molecular characterization of the group II chaperonin from the hyperthermophilic archaeum Pyrococcus horikoshii OT3.

Authors:  Mina Okochi; Hiroki Matsuzaki; Tomoko Nomura; Noriyuki Ishii; Masafumi Yohda
Journal:  Extremophiles       Date:  2004-11-09       Impact factor: 2.395

6.  Acquired Thermotolerance and Stressed-Phase Growth of the Extremely Thermoacidophilic Archaeon Metallosphaera sedula in Continuous Culture.

Authors:  C J Han; S H Park; R M Kelly
Journal:  Appl Environ Microbiol       Date:  1997-06       Impact factor: 4.792

7.  Reversion of protein aggregation mediated by Sso7d in cell extracts of Sulfolobus solfataricus.

Authors:  Annamaria Guagliardi; Lucia Mancusi; Mosè Rossi
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.